This brand name is authorized in Austria, Estonia, Ireland, Lithuania, Poland
The drug FEXERIC contains one active pharmaceutical ingredient (API):
|
1
Iron(III) citrate
UNII 63G354M39Z - FERRIC CITRATE ANHYDROUS
|
|
Ferric citrate is a phosphate binder and iron replacement product. It is used for the control of serum phosphorus levels and the treatment of iron deficiency anemia in adult patients with chronic kidney disease on dialysis. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| FEXERIC Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V03AE | Drugs for treatment of hyperkalemia and hyperphosphatemia | V Various → V03 All other therapeutic products → V03A All other therapeutic products |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1697979 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1078391 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100355711 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
